Published in J Biol Chem on February 10, 2009
Quantitative high-throughput profiling of snake venom gland transcriptomes and proteomes (Ovophis okinavensis and Protobothrops flavoviridis). BMC Genomics (2013) 1.06
The venom-gland transcriptome of the eastern coral snake (Micrurus fulvius) reveals high venom complexity in the intragenomic evolution of venoms. BMC Genomics (2013) 1.00
The role of the VEGF-C/VEGFRs axis in tumor progression and therapy. Int J Mol Sci (2012) 0.97
Novel venom gene discovery in the platypus. Genome Biol (2010) 0.94
A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol (1980) 113.75
The biology of VEGF and its receptors. Nat Med (2003) 32.13
VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol (2006) 12.09
Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell (1998) 10.32
The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem (1996) 2.75
Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet (2003) 2.51
Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell (1997) 2.24
Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. Proc Natl Acad Sci U S A (1997) 1.91
Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain. J Biol Chem (2002) 1.81
Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1. J Biol Chem (1999) 1.61
Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc Natl Acad Sci U S A (1999) 1.51
Molecular and functional diversity of vascular endothelial growth factors. Mol Divers (2006) 1.50
Bitis gabonica (Gaboon viper) snake venom gland: toward a catalog for the full-length transcripts (cDNA) and proteins. Gene (2004) 1.38
Accelerated evolution in the protein-coding regions is universal in crotalinae snake venom gland phospholipase A2 isozyme genes. Proc Natl Acad Sci U S A (1995) 1.22
Accelerated evolution of Trimeresurus flavoviridis venom gland phospholipase A2 isozymes. Proc Natl Acad Sci U S A (1993) 1.08
Molecular diversity and accelerated evolution of C-type lectin-like proteins from snake venom. Toxicon (2005) 1.02
A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1. J Biol Chem (2004) 0.97
Unusually high conservation of untranslated sequences in cDNAs for Trimeresurus flavoviridis phospholipase A2 isozymes. Proc Natl Acad Sci U S A (1992) 0.92
Viral vascular endothelial growth factors vary extensively in amino acid sequence, receptor-binding specificities, and the ability to induce vascular permeability yet are uniformly active mitogens. J Biol Chem (2003) 0.89
Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1. J Biol Chem (2004) 0.89
Snake venom components affecting blood coagulation and the vascular system: structural similarities and marked diversity. Curr Pharm Des (2007) 0.88
Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2). J Biol Chem (2003) 0.88
Vascular endothelial growth factor VEGF-like heparin-binding protein from the venom of Vipera aspis aspis (Aspic viper). Biochemistry (1999) 0.87
A set of loop-1 and -3 structures in the novel vascular endothelial growth factor (VEGF) family member, VEGF-ENZ-7, is essential for the activation of VEGFR-2 signaling. J Biol Chem (2003) 0.86
Vascular endothelial growth factors encoded by Orf virus show surprising sequence variation but have a conserved, functionally relevant structure. J Gen Virol (2002) 0.85
Augmentation of vascular permeability of VEGF is enhanced by KDR-binding proteins. Biochem Biophys Res Commun (2007) 0.85
Purification and characterization of a growth factor-like which increases capillary permeability from Vipera lebetina venom. Biochem Biophys Res Commun (2000) 0.84
Identification of the heparin-binding region of snake venom vascular endothelial growth factor (VEGF-F) and its blocking of VEGF-A165. Biochemistry (2005) 0.79
Crotalid venom vascular endothelial growth factors has preferential affinity for VEGFR-1. Characterization of Protobothrops mucrosquamatus venom VEGF. Thromb Haemost (2005) 0.79
Localization of heparin- and neuropilin-1-recognition sites of viral VEGFs. Biochem Biophys Res Commun (2006) 0.78
Adenovirus serotype 5 hexon mediates liver gene transfer. Cell (2008) 5.00
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood (2005) 2.90
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans. Pharmacogenet Genomics (2006) 2.66
Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation (2002) 2.50
Unified mode of centromeric protection by shugoshin in mammalian oocytes and somatic cells. Nat Cell Biol (2007) 2.13
p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload. Mol Cell Biol (2004) 1.95
Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol (2007) 1.71
Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice. Proc Natl Acad Sci U S A (2004) 1.63
Molecular and functional diversity of vascular endothelial growth factors. Mol Divers (2006) 1.50
Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Immunity (2012) 1.50
A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes. Gastroenterology (2013) 1.47
Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement. Nat Med (2013) 1.45
Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol (2008) 1.39
Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol (2003) 1.36
Structural basis for semaphorin signalling through the plexin receptor. Nature (2010) 1.33
Mitochondria-related male infertility. Proc Natl Acad Sci U S A (2006) 1.32
The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. J Am Coll Cardiol (2002) 1.28
Structure and function of snake venom cysteine-rich secretory proteins. Toxicon (2004) 1.26
Injectable hydrogel microbeads for fluorescence-based in vivo continuous glucose monitoring. Proc Natl Acad Sci U S A (2010) 1.24
Possible involvement of gelatinases in basement membrane damage and wrinkle formation in chronically ultraviolet B-exposed hairless mouse. J Invest Dermatol (2003) 1.23
Crystal structure of Mg2+- and Ca2+-bound Gla domain of factor IX complexed with binding protein. J Biol Chem (2003) 1.22
Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study. Mov Disord (2009) 1.22
Cloning and characterization of novel snake venom proteins that block smooth muscle contraction. Eur J Biochem (2002) 1.16
Wide distribution of cysteine-rich secretory proteins in snake venoms: isolation and cloning of novel snake venom cysteine-rich secretory proteins. Arch Biochem Biophys (2003) 1.11
Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD. J Mol Biol (2003) 1.10
RNA interference during spermatogenesis in mice. Dev Biol (2005) 1.08
Crystal structure of a CRISP family Ca2+ -channel blocker derived from snake venom. J Mol Biol (2005) 1.07
Hepatitis C virus impairs p53 via persistent overexpression of 3beta-hydroxysterol Delta24-reductase. J Biol Chem (2009) 1.04
Expression and radiation-induced phosphorylation of histone H2AX in mammalian cells. J Radiat Res (2003) 1.03
Sporadic amyotrophic lateral sclerosis of long duration is associated with relatively mild TDP-43 pathology. Acta Neuropathol (2008) 1.03
Crystal structure of von Willebrand factor A1 domain complexed with snake venom, bitiscetin: insight into glycoprotein Ibalpha binding mechanism induced by snake venom proteins. J Biol Chem (2003) 1.02
Promotion of liver and lung tumorigenesis in DEN-treated cytoglobin-deficient mice. Am J Pathol (2011) 1.02
Purification and cloning of toxins from elapid venoms that target cyclic nucleotide-gated ion channels. Biochemistry (2002) 0.99
The ANK3 bipolar disorder gene regulates psychiatric-related behaviors that are modulated by lithium and stress. Biol Psychiatry (2012) 0.98
A new gene structure of the disintegrin family: a subunit of dimeric disintegrin has a short coding region. Biochemistry (2002) 0.96
Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis. PLoS Pathog (2012) 0.96
Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes. J Hepatol (2010) 0.96
Targeted induction of interferon-λ in humanized chimeric mouse liver abrogates hepatotropic virus infection. PLoS One (2013) 0.95
Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors. Mol Ther (2009) 0.95
Rad18 is required for long-term maintenance of spermatogenesis in mouse testes. Mech Dev (2008) 0.93
Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging. Heart (2007) 0.93
Structures of pseudechetoxin and pseudecin, two snake-venom cysteine-rich secretory proteins that target cyclic nucleotide-gated ion channels: implications for movement of the C-terminal cysteine-rich domain. Acta Crystallogr D Biol Crystallogr (2008) 0.93
Damage-induced neuronal endopeptidase is critical for presynaptic formation of neuromuscular junctions. J Neurosci (2010) 0.92
Prevention of contrast-induced nephropathy by bolus injection of sodium bicarbonate in patients with chronic kidney disease undergoing emergent coronary procedures. Am J Cardiol (2011) 0.90
Venous congestive myelopathy: three autopsy cases showing a variety of clinicopathologic features. Neuropathology (2008) 0.90
Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1. J Biol Chem (2004) 0.89
Snake venom components affecting blood coagulation and the vascular system: structural similarities and marked diversity. Curr Pharm Des (2007) 0.88
Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2). J Biol Chem (2003) 0.88
Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study. Am Heart J (2007) 0.87
Immunization with a recombinant vaccinia virus that encodes nonstructural proteins of the hepatitis C virus suppresses viral protein levels in mouse liver. PLoS One (2012) 0.87
Lung carcinoma metastasis presenting as a pineal region tumor. Neuropathology (2003) 0.87
The vascular endothelial growth factor VEGF165 induces perlecan synthesis via VEGF receptor-2 in cultured human brain microvascular endothelial cells. Biochim Biophys Acta (2006) 0.86
Effects of the N/L-type calcium channel blocker cilnidipine on nephropathy and uric acid metabolism in hypertensive patients with chronic kidney disease (J-CIRCLE study). J Clin Hypertens (Greenwich) (2014) 0.85
The slender lobes gene, identified by retarded mushroom body development, is required for proper nucleolar organization in Drosophila. Dev Biol (2005) 0.85
Augmentation of vascular permeability of VEGF is enhanced by KDR-binding proteins. Biochem Biophys Res Commun (2007) 0.85
Alveolar epithelial CNGA1 channels mediate cGMP-stimulated, amiloride-insensitive, lung liquid absorption. Pflugers Arch (2011) 0.84
Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death. Brain (2009) 0.84
gamma-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-gamma-carboxy prothrombin. Biochim Biophys Acta (2002) 0.84
Crystal structure of EMS16 in complex with the integrin alpha2-I domain. J Mol Biol (2004) 0.84
Identification of vascular endothelial growth factor receptor-binding protein in the venom of eastern cottonmouth. A new role of snake venom myotoxic Lys49-phospholipase A2. J Biol Chem (2005) 0.83
Role of advanced glycation end products and growth factors in peritoneal dysfunction in CAPD patients. Am J Kidney Dis (2003) 0.83
Calpain protects the heart from hemodynamic stress. J Biol Chem (2011) 0.82
Neuromyelitis optica/Devic's disease: gene expression profiling of brain lesions. Neuropathology (2008) 0.82
Early repolarization pattern associated with sudden cardiac death: long-term follow-up in patients with chronic heart failure. J Cardiovasc Electrophysiol (2013) 0.82
Transduction of liver metastases after intravenous injection of Ad5/35 or Ad35 vectors with and without factor X-binding protein pretreatment. Hum Gene Ther (2009) 0.81
pH-Dependent structural changes at Ca(2+)-binding sites of coagulation factor IX-binding protein. J Mol Biol (2005) 0.81
Characterization of a monoclonal antibody B1 that recognizes phosphorylated Ser-158 in the activation peptide region of human coagulation factor IX. J Biol Chem (2006) 0.81
Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure. Am J Cardiol (2011) 0.80
p53 Protein interacts specifically with the meiosis-specific mammalian RecA-like protein DMC1 in meiosis. Carcinogenesis (2004) 0.80
Structural divergence of cysteine-rich secretory proteins in snake venoms. J Biochem (2008) 0.80
Activation of heparanase by ultraviolet B irradiation leads to functional loss of basement membrane at the dermal-epidermal junction in human skin. Arch Dermatol Res (2011) 0.80
Identification of the heparin-binding region of snake venom vascular endothelial growth factor (VEGF-F) and its blocking of VEGF-A165. Biochemistry (2005) 0.79
Structural characterization of EMS16, an antagonist of collagen receptor (GPIa/IIa) from the venom of Echis multisquamatus. Biochemistry (2003) 0.79
Control of radiosensitivity of F9 mouse teratocarcinoma cells by regulation of histone H2AX gene expression using a tetracycline turn-off system. Cancer Res (2004) 0.79
Catalytically inactive phospholipase A2 homologue binds to vascular endothelial growth factor receptor-2 via a C-terminal loop region. Biochem J (2008) 0.79
Spinocerebellar ataxia type 2 (SCA2) is associated with TDP-43 pathology. Acta Neuropathol (2011) 0.79
Bral2 is indispensable for the proper localization of brevican and the structural integrity of the perineuronal net in the brainstem and cerebellum. J Comp Neurol (2012) 0.79
Localization of heparin- and neuropilin-1-recognition sites of viral VEGFs. Biochem Biophys Res Commun (2006) 0.78
Stable expression of neurogenin 1 induces LGR5, a novel stem cell marker, in an immortalized human neural stem cell line HB1.F3. Cell Mol Neurobiol (2009) 0.78
Survival motor neuron (SMN) protein in the spinal anterior horn cells of patients with sporadic amyotrophic lateral sclerosis. Brain Res (2010) 0.78
Alteration of midkine expression in the ischemic brain of humans. J Neurol Sci (2002) 0.78
Crystallization and preliminary X-ray diffraction analyses of pseudechetoxin and pseudecin, two snake-venom cysteine-rich secretory proteins that target cyclic nucleotide-gated ion channels. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.78
Widespread ischemic brain lesions caused by vasculopathy associated with neurofibromatosis type 1. Neuropathology (2010) 0.78
Induction of instability of p34(cdc2) expression by treatment with cisplatin (CDDP) in mouse teratocarcinoma F9 cells. Cancer Lett (2002) 0.78
Inter-individual differences in baseline coagulation activities and their implications for international normalized ratio control during warfarin initiation therapy. Clin Pharmacokinet (2012) 0.78
Sodium bicarbonate improves long-term clinical outcomes compared with sodium chloride in patients with chronic kidney disease undergoing an emergent coronary procedure. Circ J (2008) 0.78
Clinical significance of cerebrospinal fluid inhibitory titers of antibiotics, based on pharmacokinetic/pharmacodynamic parameters, in the treatment of bacterial meningitis. J Infect Chemother (2009) 0.77
Specific distribution of VEGF-F in Viperinae snake venoms: isolation and characterization of a VGEF-F from the venom of Daboia russelli siamensis. Arch Biochem Biophys (2005) 0.77
Characterization and preliminary crystallographic studies of EMS16, an antagonist of collagen receptor (GPIa/IIa) from the venom of Echis multisquamatus. J Biochem (2003) 0.77
Heparanase activation induces epidermal hyperplasia, angiogenesis, lymphangiogenesis and wrinkles. Exp Dermatol (2010) 0.77
Increased intraatrial conduction abnormality assessed by P-wave signal-averaged electrocardiogram in patients with Brugada syndrome. Pacing Clin Electrophysiol (2011) 0.77
Crystallization and preliminary crystallographic studies of dimeric disintegrins from the venom of two Agkistrodon snakes. Acta Crystallogr D Biol Crystallogr (2001) 0.77
Age- and gender-related differences of plasma prothrombin activity levels. Thromb Haemost (2007) 0.77